IRADIMED CORPORATION
Moat Score — IRADIMED CORPORATION
Total Moat Score
13 / 30
| Moat Factor | Score | Analysis |
|---|---|---|
| Intangible Assets Patents, trademarks, brand strength, or regulatory licenses that protect a company's products or services from being freely copied by competitors. | 3 / 5 | iRadimed's core IP is the engineering know-how behind its non-magnetic, ultrasonic-motor MRidium pump, which functions safely inside 0.2T-3T MRI fields where conventional electromagnetic pumps cannot operate. This is a real, hard-won technical barrier, but it is concentrated in a single product family rather than a broad patent estate. |
| Cost Advantage A durable ability to produce goods or services more cheaply than competitors — through scale, unique access to cheap inputs, location, or process — that lets a company undercut rivals or out-earn them at the same price. | 1 / 5 | iRadimed is a sub-scale device manufacturer assembling products from purchased, sometimes single-sourced components in one Florida facility; it has no structural cost advantage over larger device makers like GE Healthcare or Philips, and its December 2024 motor technology transfer was aimed at supply security, not cost leadership. |
| Pricing Power The ability to raise prices without losing meaningful business, because the product or service is differentiated, mission-critical, or has few good substitutes. | 4 / 5 | iRadimed has unusually strong pricing power for its size because its last direct MRI-compatible pump competitor, Bayer's Continuum, exited the market in 2015, leaving only indirect 'shielded box' alternatives from B. Braun, Fresenius Kabi, and MIPM; this near-absence of direct competition in pumps is the single biggest driver of the company's roughly 30% operating margin. |
| Network Effect The product or service becomes more valuable to every user as more people or organizations use it, making an established leader harder to displace. | 0 / 5 | iRadimed's pumps and monitors are standalone hospital devices with no network effect: a hospital's MRidium pump does not become more valuable as other hospitals adopt the same device. |
| Switching Costs The money, time, or operational disruption a customer would face switching to a competitor, which locks in existing customers and supports renewals. | 3 / 5 | Once hospital staff are trained on the MRidium pump or 3880 monitor and standing orders and disposable IV tubing sets are built around it, replacing the equipment means retraining clinical staff and re-validating a new device inside MRI safety protocols; the filing itself notes customers are reluctant to switch monitor vendors once established. |
| Efficient Scale A market that can only profitably support a small number of players, so incumbents face limited threat from new entrants even without other defenses. | 2 / 5 | The MRI-compatible pump market is a genuinely narrow niche -- the company estimates only around 27,350 suitable installed MRI scanners worldwide -- which likely discouraged Bayer from re-entering after its 2015 exit, but the niche is not so small that it has kept larger diversified players like GE Healthcare and Philips out of the adjacent monitoring category. |